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The increasing use of ionising radiation for diagnostic purposes has raised concern about potential iatrogenic damage, especially in
children. In this review, we discuss some aspects of radiation-induced cancer in relation to age at exposure and measures that should
be taken for limiting exposure in this sensitive population.
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Wilhelm Roentgen’s discovery of X-rays in 1895, followed by
Henri Becquerel’s discovery of radioactivity in 1896, led to the
introduction of man-made radiation. Among the important
applications of these new sources of ionising radiation (IR) was
their use in medical diagnosis and treatment, which spread quickly
throughout the twentieth century.
Within a short time after these discoveries, reports of acute
adverse effects of radiation, such as skin damage among radiation
workers, began to appear. The first case of death associated with
radiation-induced skin cancer was reported in 1904, while in 1911
the first case of radiation-induced leukaemia was described in a
physician (Finch, 2007). Later, in the 1940s, reports of studies on
mortality among physicians showed an excess of leukaemia and
other cancer (attributed to exposure to IR) among radiologists and
dermatologists in comparison with other physicians (Dublin and
Spiegelman, 1948).
In 1913, the German Roentgen Society provided professional
guidelines aimed at reducing the dangers of radiation exposure to
medical workers. Among the recommendations of the British
X-ray and Radium Protection Committee published several years
later were a limitation of maximum work schedules, required
amounts of leisure time and special accommodations for the
workers (Committee for Review and Evaluation of the Medical
Use Program of the Nuclear Registry Commission, 1996). The
International Commission on Radiological Protection (ICRP),
established in 1928, introduced important concepts such as
‘tolerance dose’, which served as an upper limit for the exposure
of workers, and ‘effective dose’, which considers the overall effect
of irradiation at different areas of the body (Committee for Review
and Evaluation of the Medical Use Program of the Nuclear Registry
Commission, 1996).
During the second half of the twentieth century, epidemiological
data on radiation-induced cancer began to accumulate. Among the
important sources of such data were a series of papers from the
Life Span Study (LSS) cohort of atomic bomb (A-bomb) survivors.
In addition, follow-up studies of cohorts treated with radiotherapy
for benign conditions or cancer, as well as children exposed to
lower doses because of repeated diagnostic procedures, contri-
buted to our understanding of the dose–response relationship
between exposure and risk.
In 1977, the ICRP introduced a system of dose limitations based
on the principle of keeping exposures to radiation ‘As Low As is
Reasonably Achievable’ (ALARA). This system included (1)
justification – no practice (causing exposures of people to
radiation) shall be adopted unless its introduction produces a
positive net benefit (should not cause more harm than good), (2)
optimisation – all exposures should be kept as low as reasonably
achievable, economic and social factors being taken into account,
and (3) dose limits – the dose equivalent to individuals shall not
exceed the limits recommended for the appropriate circumstances
(US Department of Energy, 1997).
CHILDHOOD EXPOSURE TO IR
Specific concern over the potentially harmful effects of exposure to
radiation in children began to develop in the 1940s when it was
suggested that fluoroscopy use in infants should be restricted
according to clinical indications, and that attention should be
given to calibrating the machines to limit the exposure (Buschke
and Parker, 1942). In the 1950s, Alice Stewart proposed that
exposure to weak irradiation could initiate malignant changes in a
foetus or very young child. This hypothesis was based on the
findings of a case–control study which showed that almost twice
as many mothers of children who died from leukaemia or
malignant disease before the age of 10 had undergone X-ray
examinations of the abdomen during pregnancy (pelvimetry) in
comparison with mothers of controls (Stewart et al, 1956). Later
analyses showed that this excess risk was inversely related to foetal Revised 10 February 2009; accepted 27 February 2009
*Correspondence: Dr S Sadetzki, Cancer and Radiation Epidemiology
Unit, Sheba Medical Center, Gertner Institute for Epidemiology and
Health Policy Research, Tel Hashomer 52621, Israel;
E-mail: siegals@gertner.health.gov.il
British Journal of Cancer (2009) 100, 1021–1025
& 2009 Cancer Research UK All rights reserved 0007– 0920/09 $32.00
www.bjcancer.comage and increased with the number of films taken (Bithell and
Stewart, 1975).
An increased susceptibility of children to radiation-induced
cancer is biologically plausible because of the fact that their tissues
are still growing and therefore the dividing cells are more prone
to somatic genetic damage. In addition, children have a longer
life expectancy during which oncogenic effects may develop
(Brody et al, 2007; Shah and Platt, 2008).
The purpose of this review is to summarise data on the
relationship between childhood exposures to external IR and
cancer risk, with specific attention to the need for adequate
measures for limiting the risk of exposure in this sensitive
population.
ASSOCIATION BETWEEN AGE AT EXPOSURE AND
RISK
Estimates of excess risk associated with exposure to IR are
generally presented in terms of excess relative risk per gray (ERR
per Gy) and excess absolute risk (EAR per Gy). The ERR associated
with an exposure represents the ratio of the difference between the
rate of the disease in the exposed and unexposed groups to the rate
in the unexposed group. The ERR per dose is defined on the basis
of the assumption that the ERR is proportional to the dose and
represents the ERR for a unit dose of radiation. Excess absolute
risk (EAR) per dose refers to the additional risk that a radiation
dose contributes beyond the background risk.
A recent publication from the LSS on risk of solid cancer
(malignancies that form tumours in solid organs, as opposed to
leukaemia, which affects the blood) among atomic bomb survivors
exposed to radiation doses ranging from o0.005 to 4Gy included
data showing the effect of age at exposure on excess risk for all
solid cancer and by specific sites (Preston et al, 2007). For all solid
cancer, the ERR per Gy decreased with increasing age at exposure,
with estimates at attained age 70 of 0.72 (90% CI: 0.52–0.98), 0.64
(90% CI: 0.51–0.79), 0.41 (90% CI: 0.33–0.50), and 0.41 (90% CI:
0.29–0.53) for survivors aged 0–9, 10–19, 20–39, and 40þ,
respectively, at the time of the bombings. The EARs per 10
4 PY of
solid cancer at attained age 70 in the LSS were also higher for those
who were younger at the time of exposure, with rates of 90 (90%
CI: 68–113), 52 (90% CI: 43–60), and 30 (90% CI: 22–39) for ages
10, 30, and 50, respectively.
The pattern of decreasing risk with increasing age at exposure
was particularly striking for thyroid cancer (Preston et al, 2007).
This inverse association is supported by data from cohorts
exposed to radiotherapy for cancer during childhood (Sigurdson
et al, 2005), tinea capitis (Sadetzki et al, 2006), and other benign
conditions, as shown in Figure 1A. The results of a pooled analysis,
including individuals from six studies who were under the age of
15 at the time of radiation exposure, yielded an ERR per Gy of
7.7 (95% CI: 2.1–28.7) and an EAR per 10
4 PY Gy of 4.4 (95% CI:
1.9–10.1) for risk of thyroid cancer. A trend for decreasing risk
with increasing age at irradiation was observed (Ron et al, 1995).
The investigators suggested that these findings might indicate a
greater radiation effect during periods of rapid cell proliferation,
which occur when the thyroid gland is developing.
For many years, brain tissue was considered to be resistant to
radiation damage. Four studies that have quantified the risk
between IR and brain cancer have reported estimations that vary
in terms of the magnitude of the risk per Gy. The Israeli tinea
capitis study found an ERR per Gy of 1.98 (95% CI: 0.73–4.69) for
glioma after a mean dose to the brain of 1.5Gy (range: 1.0–6.0Gy)
(Sadetzki et al, 2005); a pooled analysis of two Swedish cohorts of
infants who received radium treatment for haemangiomas (mean
absorbed intracranial dose: 7cGy; range: 0–11.5Gy) estimated the
ERR per Gy for all brain tumours as 2.7 (95% CI: 1.0–5.6)
(Karlsson et al, 1998); a childhood cancer survivor study reported
an ERR per Gy of 0.33 (95% CI: 0.07–1.71) for glioma (Neglia et al,
2006) after radiation doses ranging from o1Gy to 445Gy; and
the LSS found an ERR per Gy for glioma of 0.6 (95% CI:  0.2 to
2.0) (Preston et al, 2002b). Evidence of increasing risk of brain
cancer with younger age at exposure has been provided by the first
three aforementioned studies (Figure 1B), whereas for the LSS, the
risk was non-significantly higher for those exposed before age 20.
It is interesting to note that even among infants, the risk of those
treated for haemangioma when they were o5 months old was
much greater than that of those treated over the age of 5 months
(Figure 1B).
Radiation effects on female breast cancer rates have been
studied extensively. The results of pooling eight cohorts showed
that age at exposure is an important modifier of the breast cancer
ERRs with higher risks for younger ages, so that exposure after age
50 carries a lower risk than exposure earlier in life. No simple
unified summary model adequately described the excess risks in all
populations, suggesting that host factors (e.g. earlier benign breast
disease or reproductive factors) are determinants of the variations
in the ERR with age at exposure (Preston et al, 2002a).
Among Canadian women who were examined by fluoroscopy
during treatment for tuberculosis (range of radiation dose:
o0.01–X10 Sv), the ERR per Sv for breast cancer mortality was
shown to decrease with increasing age at exposure (P¼0.0003)
(Howe and McLaughlin, 1996). In the latest results of the LSS, a
statistically significant age-at-exposure effect of  19% per decade
increase in ERR (90% CI:  33 to  4%) was noted for breast
cancer. However, the addition of attained age to the model
improved the fit significantly and reduced the age-at-exposure
effect estimate to 0, whereas both attained age and age at exposure
had a significant joint effect on the EAR (Preston et al, 2007).
Differences between studies still remain regarding the influence of
age at exposure around menarche and menopause on the risk.
A strong inverse association between age at exposure and risk
has also been noted for non-melanoma skin cancer (Po0.001) in
the LSS (Preston et al, 2007). This finding is supported by data
from the tinea capitis study, in which the fitted relative risk for
basal cell carcinoma decreased from 19.0 (95% CI: 14.4–28.4) for
irradiation at age p4, to 5.9 (95% CI: 3.3–11.0) for exposure at
age 5–9, and 2.0 (95% CI: 1.3–4.0) among those exposed at ages
10–15 (Ron et al, 1991).
It is interesting to note that for lung cancer a different picture
was observed, in which the ERR increased with increasing age at
exposure. This finding may be attributed to the additive joint
effects of radiation and smoking (Pierce et al, 2003; Preston et al,
2007).
The evaluation of childhood cancer risk in the LSS study was
limited by the fact that the tumour registries were only established
in 1958, and therefore, data on cancer incidence during the first
13 years after the bombings were unavailable. An assessment of
risk among survivors diagnosed during adolescence identified
eight cases of solid cancers between the ages of 13 and 19, yielding
an ERR per Gy of 19.8 (90% CI: 6–77) for ageo20years. It has
been suggested that if follow-up of the cohort had been initiated at
an earlier stage, the risks associated with childhood cancer would
have been extremely high (Preston et al, 2007).
AGE AT EXPOSURE AND TEMPORAL PATTERNS OF
RISK (ATTAINED AGE AND LATENCY PERIOD)
Age at exposure, time since exposure, and attained age are
collinear variables, and their combined effect differs from the
individual effects of each factor. Thus, the association between
these factors and radiation-induced cancer risk can only be
estimated for two of the three at any one time, and the true causal
effect of age at exposure on radiation-induced cancer cannot be
assessed (Lagarde, 2006).
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with increasing attained age, for any age at exposure. The age-at-
exposure effect is shown by a 20% decrease in attained-age-specific
ERRs per decade increase in age at exposure. In contrast, EARs
were shown to increase throughout life regardless of the age at
exposure, and there have been indications that for solid cancers,
attained-age-specific EARs are higher for those exposed at younger
ages (Preston et al, 2003).
REDUCING EXPOSURE TO IR IN CHILDREN
A profound discussion on the dose–response association is
beyond the scope of this review. Scientific consensus groups as
well as regulatory agencies have endorsed the use of the linear,
no-threshold model in determining standards of protection from
the risk of solid cancer associated with exposure to IR at low
dose levels (Committee for Review and Evaluation of the Medical
Use Program of the Nuclear Registry Commission, 1996). The
data described above highlight the need for applying the ALARA
principle for reducing exposure to IR, with specific attention to
children, who represent a subgroup with increased radiosensi-
tivity. The importance of this approach has increased as a result
of the growing use of diagnostic procedures that usually involve
low-dose radiation, and specifically for computed tomography
(CT) scanning, which commonly involves 30–90 mSv per 2–3
scans. This dose is comparable to the low doses of radiation
(5–150 mSv), to which a subgroup of 25000 A-bomb survivors was
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Figure 1 (A) Excess relative risk of thyroid cancer by age at exposure among selected cohorts exposed to ionising radiation. Dose ranges refer to doses
to the thyroid gland. (B) Excess relative risk of brain cancer by age at exposure among selected cohorts treated with radiotherapy. Dose ranges refer to
doses to the brain. *Please note the change in the scale of the y-axis.
#ERR estimates presented here are for survivors aged o10 and X10 years who were
exposed to low doses.
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associated with the latter doses suggests that the organ doses
corresponding to a CT study may also increase the risk of cancer
(Brenner and Hall, 2007).
It should also be noted that a dramatic increase in the use of CT
over time has been observed, as indicated by estimates of 2 million
per year in the United States in 1980 rising to 69 million in 2007
(Hall and Brenner, 2008). Data from the United States and Europe
have shown that although CT constitutes only 5–10% of all
imaging procedures, 40–67% of all exposure to medical diagnostic
radiation can be attributed to this procedure (Sadetzki, 2007).
An important development in the attempt to reduce unnecessary
exposure of children to IR was the recent establishment of the
Alliance for Radiation Safety in Pediatric Imaging. This coalition,
which comprises members of leading medical societies, agencies
and regulatory groups, aims to influence patient care and change
practice through an educational and awareness campaign entitled
‘Image Gently’. The campaign includes a four-point strategy
regarding performing pediatric CT scans, including the need to
reduce or ‘child-size’ the amount of radiation used, scan only when
necessary, scan only the indicated region, and refrain from
multiphase scanning unless it is necessary (Goske et al, 2008).
Other strategies aimed at protecting pediatric patients include
consideration of alternatives to CT, such as ultrasound and
magnetic resonance imaging, and shielding of the breast areas
(including the nipples and breast buds in young girls), thyroid,
and gonads when possible during CT scans (Shah and Platt, 2008).
The need to increase the awareness of professionals regarding
the late health effects of exposure to IR has been shown in a study
of radiography conducted in five Israeli neonatal care units, which
identified unnecessary overexposure to IR in a substantial
proportion of body regions beyond those that were ordered. This
problem was particularly prevalent in radiographs of the abdomen,
in which the neck and upper chest were exposed in 45 and 64%,
respectively, which did not comply with international recommen-
dations. Other problems encountered included the need to repeat
up to 20% of the radiographs, thereby increasing the overall
exposure of the infant to radiation, and the lack of shielding of the
gonads in most of the X-rays taken. Correction of this situation
does not require investment of resources. By simply raising
awareness among the staff with better guidelines regarding
exposure to IR, these issues can be resolved (Bader et al, 2007).
Another measure that has been proposed for limiting exposure
to diagnostic radiation in children is the incorporation of personal
information on lifetime IR exposure in computerised medical
systems. Such information could include the numbers and types of
procedures carried out, the ages at which they were carried out,
and calculations of cumulative doses absorbed by different organs.
Consideration of these factors could be important in determining
to which diagnostic examinations the patient should be referred
(Sadetzki, 2007).
Thus, there are also legal and ethical implications of exposure to
diagnostic IR that need to be addressed, such as the right of a
parent to be informed of the risks involved in the procedures
to which his or her child has been referred.
CONCLUSION
The use of IR in medicine has provided a wide range of
possibilities for diagnosis and treatment. Constant refinement
of the techniques used in radiological examinations has produced
greater resolution in imaging, facilitating greater accuracy
of assessments. However, along with the important benefits of
medical applications of IR, there are risks that need to be
considered as well. Children constitute a subgroup at greater risk
from exposure to radiation because of their greater degree of
radiosensitivity and because of the many years of life ahead of
them during which they could develop radiation-induced cancer.
In order to minimise the risks, it is essential that procedures
involving low doses of IR be used with discretion, in a responsible
way. Although the risks involved may be relatively small, the
ancient concept expressed by Hippocrates of ‘Primum non nocere’
(to help, or at least to do no harm) should serve as a guide
when assessing the appropriateness of radiation-based imaging
procedures in pediatric patients.
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